Debt-to-equity of CATALYST PHARMACEUTICALS, INC. from 31 Mar 2012 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CATALYST PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 31 Dec 2025.
  • CATALYST PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 15%, a 11% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CATALYST PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 15% -1.8% -11% 31 Dec 2025
Q3 2025 15% -2.2% -13% 30 Sep 2025
Q2 2025 15% -2% -12% 30 Jun 2025
Q1 2025 16% -2% -11% 31 Mar 2025
Q4 2024 16% -3.7% -18% 31 Dec 2024
Q3 2024 17% -3.8% -18% 30 Sep 2024
Q2 2024 17% -4.6% -21% 30 Jun 2024
Q1 2024 18% -2.8% -14% 31 Mar 2024
Q4 2023 20% +1.5% +7.9% 31 Dec 2023
Q3 2023 21% +5.1% +33% 30 Sep 2023
Q2 2023 22% +9.4% +75% 30 Jun 2023
Q1 2023 21% +8.2% +65% 31 Mar 2023
Q4 2022 19% +6.3% +52% 31 Dec 2022
Q3 2022 16% +4% +34% 30 Sep 2022
Q2 2022 13% +1% +8.9% 30 Jun 2022
Q1 2022 13% -0.37% -2.8% 31 Mar 2022
Q4 2021 12% -2.6% -17% 31 Dec 2021
Q3 2021 12% -6.2% -35% 30 Sep 2021
Q2 2021 11% -10% -47% 30 Jun 2021
Q1 2021 13% -10% -44% 31 Mar 2021
Q4 2020 15% -9.6% -39% 31 Dec 2020
Q3 2020 18% -4% -18% 30 Sep 2020
Q2 2020 22% +5.1% +31% 30 Jun 2020
Q1 2020 23% +12% +109% 31 Mar 2020
Q4 2019 24% +17% +229% 31 Dec 2019
Q3 2019 22% +17% +352% 30 Sep 2019
Q2 2019 17% +11% +222% 30 Jun 2019
Q1 2019 11% +5.7% +103% 31 Mar 2019
Q4 2018 7.4% +0.83% +13% 31 Dec 2018
Q3 2018 4.8% -2.2% -32% 30 Sep 2018
Q2 2018 5.2% -1.1% -17% 30 Jun 2018
Q1 2018 5.5% -0.64% -11% 31 Mar 2018
Q4 2017 6.6% +0.67% +11% 31 Dec 2017
Q3 2017 7.1% +0.53% +8.1% 30 Sep 2017
Q2 2017 6.2% -0.48% -7.1% 30 Jun 2017
Q1 2017 6.1% -1.4% -18% 31 Mar 2017
Q4 2016 5.9% -3.7% -38% 31 Dec 2016
Q3 2016 6.6% -5.7% -46% 30 Sep 2016
Q2 2016 6.7% -9.6% -59% 30 Jun 2016
Q1 2016 7.5% -10% -58% 31 Mar 2016
Q4 2015 9.6% -11% -54% 31 Dec 2015
Q3 2015 12% -7.1% -37% 30 Sep 2015
Q2 2015 16% -3.1% -16% 30 Jun 2015
Q1 2015 18% -7.3% -29% 31 Mar 2015
Q4 2014 21% -1.5% -6.8% 31 Dec 2014
Q3 2014 19% -2.6% -12% 30 Sep 2014
Q2 2014 19% -0.08% -0.39% 30 Jun 2014
Q1 2014 25% +7.3% +41% 31 Mar 2014
Q4 2013 22% -3.1% -12% 31 Dec 2013
Q3 2013 22% -18% -44% 30 Sep 2013
Q2 2013 20% -19% -50% 30 Jun 2013
Q1 2013 18% -20% -53% 31 Mar 2013
Q4 2012 25% 31 Dec 2012
Q3 2012 39% 30 Sep 2012
Q2 2012 39% 30 Jun 2012
Q1 2012 38% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.